M Angela Cenci Selected Research

Muscarinic M4 Receptor

1/2016	M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.
11/2015	M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Angela Cenci Research Topics

Disease

59	Parkinson Disease (Parkinson's Disease) 05/2022 - 01/2002
57	Dyskinesias (Dyskinesia) 01/2022 - 01/2002
6	Parkinsonian Disorders (Parkinsonism) 01/2020 - 06/2004
2	Dementia (Dementias) 11/2019 - 11/2015
2	Catalepsy 08/2015 - 04/2006
1	Alzheimer Disease (Alzheimer's Disease) 05/2022
1	Synucleinopathies 11/2019
1	Cognitive Dysfunction 11/2019
1	Lewy Body Disease (Lewy Body Dementia) 11/2019
1	Huntington Disease (Huntington's Disease) 01/2019
1	Chorea (Rheumatic Chorea) 01/2018
1	Substance-Related Disorders (Drug Abuse) 02/2016
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2015
1	Disease Progression 01/2014
1	Movement Disorders (Movement Disorder) 04/2007
1	Hyperkinesis 03/2006

Drug/Important Bio-Agent (IBA)

55	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 01/2002
23	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 07/2002
15	Oxidopamine (6 Hydroxydopamine)IBA 01/2019 - 01/2002
11	Pharmaceutical PreparationsIBA 11/2017 - 07/2002
3	Dopamine Receptors (Dopamine Receptor)IBA 01/2020 - 07/2009
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2010
3	Glutamic Acid (Glutamate)FDA Link 08/2015 - 07/2009
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 08/2015 - 04/2006
3	Glutamate Receptors (Glutamate Receptor)IBA 04/2014 - 04/2007
3	Serotonin (5 Hydroxytryptamine)IBA 11/2013 - 07/2009
3	Bromocriptine (Parlodel)FDA LinkGeneric 11/2009 - 01/2002
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2014
2	Sigma-1 ReceptorIBA 01/2019 - 07/2014
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2018 - 07/2010
2	Biological ProductsIBA 01/2018 - 01/2012
2	Muscarinic M4 ReceptorIBA 01/2016 - 11/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 08/2011
2	gamma-Aminobutyric Acid (GABA)IBA 08/2015 - 01/2012
2	Haloperidol (Haldol)FDA LinkGeneric 08/2015 - 04/2006
2	PlasticsIBA 04/2015 - 12/2009
2	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 12/2013 - 11/2009
2	NestinIBA 08/2011 - 11/2009
2	pyridineIBA 04/2007 - 04/2006
1	Caspase 3 (Caspase-3)IBA 05/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	SynucleinsIBA 11/2019
1	pridopidineIBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 12/2017
1	Caffeine (No Doz)FDA LinkGeneric 12/2017
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2017
1	Anesthetics (Anesthetic Agents)IBA 01/2017
1	Isoflurane FDA LinkGeneric 01/2017
1	Ketamine FDA LinkGeneric 01/2017
1	Xylazine (Xylazin)IBA 01/2017
1	Dopamine AntagonistsIBA 12/2016
1	Dihydroxyphenylalanine (Dopa)IBA 08/2015
1	N-(3-chlorophenyl)picolinamideIBA 08/2015
1	LSP1 2111IBA 08/2015
1	metabotropic glutamate receptor 4IBA 08/2015
1	hydroxide ionIBA 12/2013
1	Nerve Growth Factors (Neurotrophins)IBA 01/2012
1	Amino Acids FDA Link 01/2012
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2012
1	RNA (Ribonucleic Acid)IBA 08/2011
1	Retinaldehyde (Retinal)IBA 07/2011
1	ras-GRF1 (ras GRF1)IBA 12/2010
1	Therapeutic UsesIBA 12/2010
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 11/2010
1	DeuteriumIBA 10/2010
1	fenobamIBA 09/2010
1	CalciumIBA 07/2010
1	IEM 1460IBA 07/2010
1	AMPA Receptors (AMPA Receptor)IBA 07/2010
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2010
1	rat endothelial barrier antigenIBA 11/2009
1	5,7-Dihydroxytryptamine (5,7 Dihydroxytryptamine)IBA 07/2009
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 07/2009
1	Amphetamine (Amfetamine)FDA LinkGeneric 07/2009
1	LY 379268IBA 07/2009
1	Isradipine (Dynacirc)FDA LinkGeneric 03/2009
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 10/2007
1	SCH 23390IBA 10/2007
1	Bromodeoxyuridine (BrdU)IBA 09/2006
1	LigandsIBA 04/2006
1	methanesulfonic acid (methanesulfonate)IBA 04/2006
1	AcidsIBA 04/2006
1	metabotropic glutamate receptor type 1IBA 04/2006
1	salicylhydroxamic acid (SHAM)IBA 03/2006
1	Messenger RNA (mRNA)IBA 11/2004
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2004
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 06/2004
1	ElementsIBA 06/2004
1	Protein Phosphatase 1IBA 05/2003

Therapy/Procedure

11	Therapeutics 01/2022 - 02/2009
6	Drug Therapy (Chemotherapy) 03/2014 - 04/2007
4	Injections 01/2017 - 07/2002
3	Transplantation 12/2009 - 12/2005
2	Denervation 03/2009 - 07/2002
1	Deep Brain Stimulation 01/2020
1	Anesthesia 01/2017